Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 8-K: Bio-Path Holdings Reports First Quarter 2024 Financial Results
Bio-Path Holdings | 10-Q: Quarterly report
Bio-Path Holdings | EFFECT: Others
Bio-Path Holdings | CORRESP: CORRESP
Bio-Path Holdings | UPLOAD: Others
Bio-Path Holdings | D: Filing D
Bio-Path Holdings | S-1: General form for registration of securities under the Securities Act of 1933
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 424B5: Prospectus
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 424B5: Prospectus
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | D: Filing D
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 424B5: Prospectus
Bio-Path Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(7.1%),Daniel B. Asher(7.1%), etc.
Bio-Path Holdings | 8-K: Current report
Bio-Path Holdings | 8-K: Current report
No Data